In considering these data, it is important to note that there can be discrepancies in BRAF and NRAS mutation statuses between metastatic lesions and primary and metastatic lesions of the same tumor, and that biopsy and genetic analysis of both primary and metastatic lesions may be informative in considering prognosis and treatment options [25,26]. Here, BRAF is linked to neoplasm.